glp 1 south korea Ozempic & Wegovy in Korea: 2026 Price & Access Guide Lilly's diabetes drug Mounjaro receives

doi:10.4103/jhrs.jhrs_70_21

Gastrointestinal adverse effects are the most frequently reported and include: Nausea (very common): typically most pronounced during treatment initiation and dose escalation, often improving with continued use Diarrhoea and vomiting (very common): may contribute to dehydration risk and electrolyte disturbances if severe or prolonged Constipation (common): can alternate with diarrhoea

Three ways, whichever fits the moment

The agency recently explained that it considers the bigger picture in determining when a drug should be on its shortage list, saying, FDA generally considers a shortage to be resolved based on an evaluation of the entire market, assessing whether all backorders have been filled and supply is meeting or exceeding demand. Could things be improving